Current Studies
Are you considering volunteering for one of our active studies? Volunteering to participate in clinical research is a rewarding experience—knowing that you’ve helped future generations beat today’s medical ailments.
No Overnight Stays Required for Our Studies
Neuropathy Pain Study
Posted January 8, 2024 for Lincoln, Nebraska and Round Rock, Texas
Shooting pain down your leg? You may have painful lumbosacral radiculopathy (PLSR), often referred to as sciatica. A clinical research study is now enrolling adults for an investigational drug for chronic pain.
Who is eligible?
Be between the ages of 18 and 70
Have had symptoms of sciatica for more than three months
Have pain in one leg, with leg pain worse than back pain
Compensation for time and travel.
Meningococcal Vaccine Research Study
Posted December 2, 2023 for Lincoln, Nebraska and Round Rock, Texas
Help us learn more about a study vaccine for meningitis.
Who is eligible?
Healthy volunteers 10 to 17 years of age
No previous meningococcal vaccines or a single previous dose of meningococcal vaccine more than four years ago
Additional criteria may apply.
Compensation for time and travel up to $2,200.
Attention Seniors!
Do You Suffer from UTIs?
Posted November 22, 2024 for Lincoln, Nebraska
A clinical research study is enrolling senior adults with a history of urinary tract infections.
Who is Eligible?
65 years of age or older
E.coli Study for Individuals 65 Years or Older
Posted April 4, 2023 for Round Rock, Texas
Help us find a way to prevent bloodstream infections.
People aged 65 or older, with a history of UTI, are at an increased risk of developing a bloodstream infection, caused by an E. coli bacteria.
Who is Eligible?
Are 65 years of age or older
Have had a UTI in the past 2 years
Feel comfortable, or have a caregiver who is comfortable, using an application on a smartphone
Baby COVID-19 Vaccine Study
Posted January 2, 2023 for Lincoln, Nebraska
The Covid-19 story is ever-evolving. Join in a nationwide effort to try to protect our kids from this dangerous disease.
Reported COVID-19 cases among children spiked dramatically in 2022 during the Omicron variant winter surge, peaking at 1,150,000 cases reported in one week. Almost 13.3 million children have tested positive for COVID-19 since the onset of the pandemic according to available state reports.
Source: American Academy of Pediatrics
Who is Eligible?*
Healthy infants 12 weeks to less than 6 months of age
Be in good health and not had COVID-19 or close contact with someone with COVID-19 within the past 14 days
Have parent/guardian able to attend all trial visits
Participation will last approximately 15 months
Compensation for time and travel is up to $1,800.
Previous Studies
Potentially Protect Against Seasonal Flu and COVID-19 With a Single Injection
Posted October 27, 2023 for Lincoln, Nebraska
Seasonal flu and COVID-19 target the lungs and breathing passages and are easily spread from person to person, regardless of age.
Who is Eligible?*
Age 50 or older
Be in good health
Be vaccinated against COVID-19 and have received your last COVID-19 vaccine at least 3 months prior to your vaccination visit
Qualified participants will receive compensation for time and travel.
Attention: People Living with Alzheimer’s Disease and Those Caring For Them
Posted May 25, 2023 for Round Rock, Texas (CLOSED)
Research is underway for an investigational pill that may help treat this most common type of dementia. This pill offers a novel mechanism to attack neurodegenerative diseases. It will be tested for potency and speed of action with the goal to improve cognitive ability in Alzheimer's patients.
Currently, no treatment is available to stop or reverse the progression of Alzheimer’s.
Who is Eligible?*
Age 55 - 85
Have mild to moderate diagnosis of Alzheimer’s Disease
Have a study partner in frequent contact with the participant
Compensation for time and travel: $600 each for volunteer and caregiver.
Join the CMV Victory Trial
Posted April 24, 2023 for Lincoln, Nebraska (CLOSED)
What is CMV? Cytomegalovirus, is a leading cause of birth defects around the world. CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects.
Currently, there is no approved vaccineagainst CMV.
CMV is the #1 infection that causes birth defects in the U.S. and one of the most common infectious causes of birth defects globally.
Who is Eligible?*
Women, in good health, between 16 and under 18 years of age
Not pregnant or planning to become pregnant within the next 10 months
Compensation for time and travel can be more than $2,600
Flu Season is Fast Approaching!
Posted October 6, 2023 for Round Rock, Texas and Lincoln, Nebraska (CLOSED)
Research studies are underway for new strains of the virus.
Compensation for time and travel.
RSV & FLU Clinical Trial
Posted October 12, 2023 for Lincoln, Nebraska (CLOSED)
If you are age 65 or older you may qualify.
Who is Eligible?*
Age 65 or older
You can NOT have had the flu vaccine this year nor can you have ever received the RSV vaccine
Qualified participants will receive up to $840 for time and travel.
Child COVID-19 Vaccine Study
Posted July 28, 2022 for Lincoln, Nebraska (CLOSED)
The Covid-19 story is ever-evolving. Join in a nationwide effort to try to protect our kids from this dangerous disease.
Reported COVID-19 cases among children spiked dramatically in 2022 during the Omicron variant winter surge, peaking at 1,150,000 cases reported in one week. Almost 13.3 million children have tested positive for COVID-19 since the onset of the pandemic according to available state reports. Source: American Academy of Pediatrics
Who is Eligible?*
Children 6 months to under 2 years
Compensation for time and travel is more than $3,000.
Click here to learn more about this study and watch a short video.
Obesity Research Study
Posted August 17 for Lincoln, Nebraska (CLOSED)
We are seeking healthy participants for an obesity clinical trial.
– Obesity is a worldwide epidemic. Currently 1 in 5 adults are considered obese.
– Obesity can lead to heart disease, type 2 diabetes and some cancers.
– Anti-obesity medications are recommended for patients who are not able to achieve and maintain clinically significant weight loss with lifestyle interventions.
Who is Eligible?
19 years or older and in relatively good health
The study runs for approximately 6 months
Compensation:
Compensation for time and travel and study-related medical exams are included.
Child COVID-19 Vaccine Study.
Posted April 21, 2023 for Lincoln, Nebraska (CLOSED)
Someone little can make a big difference.
The KidCOVE Study is a research study to test an investigational vaccine that may protect children who are ages 6 months to under 6 years of age from getting sick if they come into contact with SARS-COV-2, the virus that causes COVID-19.
Who is Eligible?
Between 6 months and under 6 years of age
In good health or with stable chronic conditions
Not have had COVID-19 within 90 days prior to study enrollment
Norovirus in Babies Can Lead to Dangerous Dehydration
Posted July 5, 2023 for Lincoln, Nebraska (CLOSED)
Research is underway for a vaccine to prevent norovirus in infants and ultimately prevent acute gastroenteritis. Vaccinating at an early age could reduce severe illness in babies and young children.
Norovirus is the leading cause of vomiting and diarrhea, and foodborne illness in the US. The norovirus can spread very quickly and easily. Currently, there is no vaccine to cure norovirus infection in babies.
Who is Eligible?
We are looking for newborns less than 2 months old to take part in this study.
Participation includes study visits at no cost to you.
Compensation:
Compensation for time and travel is up to $425.
A Clinical Trial for Investigational Pediatric RSV and hMPV Vaccines
Posted May 17, 2023 for Lincoln, Nebraska (CLOSED)
Precious Lungs Need Protection from Serious Respiratory Illness
The Rhyme Trial is helping researchers learn more about Moderna’s investigational RSV and hMPV vaccines, which may help protect people from getting sick if they come into contact with the viruses.
Who is Eligible?
Healthy children 5 months to 23 months
Be in good health
Our Fight Against COVID-19 Continues
Posted July 19, 2023 for Lincoln Nebraska and Round Rock, Texas (CLOSED)
A unique investigation of monoclonal antibodies is the basis for this COVID prevention study.
The COVID-19 pandemic is like nothing we’ve seen in more than a century, and it has changed each and every one of our lives.
Who is Eligible?*
If you are 18 or older, you may qualify
Compensation for time and travel up to $2,800.
mRNA Flu Vaccine Study
Posted October 11, 2022 for Lincoln, Nebraska (CLOSED)
Could you be part of the next vaccine breakthrough?
Today’s flu vaccines are updated each year to prevent infection with the specific strains of the flu that scientists and health officials expect to be common that year. It takes several months to make the vaccines.
Recent advances in mRNA-based vaccines have taught us more about how mRNA technology can be used, take less time to make and possibly can be more effective.
Who is Eligible?
Currently enrolling 64 and over
Generally healthy or have stable conditions
Compensation for time and travel is approximately $800.
Are You 60 or Over?
Posted February 15, 2023 for Lincoln, Nebraska and Round Rock, Texas (CLOSED)
Join a Clinical Trial – Make a Difference and Make Some Cash!
Details:
Compensation for time and travel available for qualified participants
All study related doctor visits/treatments are free of charge
If you’re 60 years old or older sign up today to see if you qualify
Clinical Trial for Seasonal Influenza
Posted August 26, 2022 for Round Rock, Texas (CLOSED)
Join this clinical trial for an investigational mRNA vaccine aimed at preventing seasonal influenza infection. Seasonal influenza is a respiratory illness caused by the influenza virus.
An mRNA vaccine has the potential to offer broader protection by responding to strain changes more quickly. It also may create stronger immune responses and improve protection in older adults.
Source: Rockman S, Laurie KL, Parkes S, Wheatley A, Barr IG. New technologies for influenza vaccines. Microorganisms. 2020;8(11):1745.
Who is Eligible?*
Age 66 or older
Not pregnant or planning to become pregnant for at least 3 months following your vaccine visit
Compensation more than $800 for time and travel.
RSV Clinical Study for Seniors
Posted April 27, 2022 for Round Rock, Texas (CLOSED)
Respiratory Syncytial Virus (RSV) is a highly contagious seasonal respiratory virus.
The virus is one of the most common causes of acute respiratory infections in older adults, young children, and those with underlying health conditions.
RSV disproportionately impacts adults over 60 years, who are more likely to develop a lower respiratory tract infection.
Who is Eligible?*
60 years of age or older
Healthy or have one or more chronic medical conditions
Able to use a smartphone or tablet application to record information during the study
Compensation for time and travel included
Attention: Pregnant Moms.
Pursuing a better option for Group B Strep.
Posted August 18, 2022 for Lincoln, Nebraska (CLOSED)
A study is underway for a vaccine aimed at the prevention of group B streptococcal disease in young children by the active immunization of pregnant moms.
Group B streptococcus (GBS) is most frequently found in the very young—newborns and infants. GBS can cause more serious illness in infants, including sepsis, meningitis, pneumonia, and death. Pregnant women may be particularly susceptible to GBS disease as well.
Who is Eligible?
Women 18-40 years of age
Healthy or having stable chronic conditions
Pregnant between 24 weeks and 35 weeks
Compensation over $2,000 for time and travel.
Seniors with RSV at High Risk
Posted May 24, 2022 for Lincoln, Nebraska (CLOSED)
Respiratory Syncytial Virus (RSV) is a highly contagious seasonal respiratory virus. Older adults are at high risk for severe RSV infections, including pneumonia. According to the CDC, every year RSV leads to 177,000 hospitalizations in adults 65 years and older, and 14,000 deaths among those 65 years and older.
Who is Eligible?
Healthy, 50 years of age or older
Compensation for time and travel approximately $1,400
Infant Formula Research Study
Posted November 4, 2021 for Lincoln, Nebraska (CLOSED)
Do you have a FUSSY newborn baby? Be Well Clinical Studies is looking for babies to participate in a 1-month long infant formula study.
Study formula provided at no cost. Compensation for time and travel up to $750. Click below to learn more about this study.
Infant RSV Research Study
Posted February 16, 2022 for Lincoln, Nebraska (CLOSED)
Did you know RSV is the #1 cause of hospitalization during a baby’s first year?
Source: Centers for Disease Control and Prevention
Help us learn more about infant RSV.
Who is Eligible?*
• Infants and toddlers 6 to 18 months of age
• Compensation up to $1,700 for time and travel
*Additional eligibility criteria may apply.
Clinical Study for Senior RSV
Posted January 21, 2022 for Lincoln, Nebraska (CLOSED)
Respiratory Syncytial Virus (RSV) is a highly contagious seasonal respiratory virus.
The virus is one of the most common causes of acute respiratory infections in older adults, young children, and those with underlying health conditions.
We are seeking healthy seniors ages 60-75 for a research study of an investigational vaccine for the prevention of RSV.
Up to $1,000 compensation for time and travel
Meningococcal Vaccine Research Study
Posted December 22, 2021 for Lincoln, Nebraska (CLOSED)
Help us learn more about a study vaccine for meningitis.
Who is Eligible?*
• You are between the ages of 10-25
• You have never received a vaccine for meningitis B (with the exception of meningococcal C vaccination if the last dose of MenC was received at 24-months of age or earlier)
*Additional eligibility criteria apply.
Maternal RSV Vaccine Study
Posted January 15, 2021 for Lincoln, Nebraska (CLOSED)
RSV A common respiratory virus that usually causes mild, cold-like symptoms in children younger than 1 year of age.
A common respiratory virus that usually causes mild, cold-like symptoms. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia in children younger than 1 year of age.
Almost all children will be infected with RSV by their second birthday.
Studies show that by vaccinating pregnant mothers, babies can receive immunity against RSV before they are born.
Pediatric COVID-19 Study
Posted September 7, 2021 for Lincoln, Nebraska (CLOSED)
The focus of this study is on children, newborn to 2 years who have tested positive for Covid-19. The intent is to test a treatment option in the hopes of preventing long-term side effects. This study is looking at those most at-risk including: infants before their first birthday and one year olds with certain chronic illnesses.
Potential study participants need to have tested positive for Covid-19 for the first time with 72 hours of study treatment. Be Well Clinical Studies can test for Covid-19 at our clinic location if your child is having symptoms.
The study’s drug treatment will be given to participants with early symptoms of Covid-19. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to our clinic, with the remainder of assessments performed in the home or by phone.
Senior Vaccination Study
Posted July 22, 2020 for Lincoln, Nebraska (CLOSED)
Please contact us if you are 65 or over and have not received your vaccine to prevent pneumonia.
Be Well Clinical Studies is always looking for people ages 55+ to sign up for our senior vaccine studies…[more]
COVID-19 Investigational Vaccine Study
Posted April 16, 2021 for Lincoln, Nebraska (CLOSED)
Together we’ve experienced a significant health crisis that we hope we’ll only see once in our lifetime. During trying times for so many, maybe you have asked yourself, what can I do to help?
Be Well Clinical Studies is running a clinical trial testing an investigational vaccine for COVID-19. Here’s our collective opportunity to contribute to the cause.
This vaccine is developed differently than the currently available ‘emergency-use’ vaccines.